Skip to main content

BASES ESTRUCTURALES Y MECANISTICAS DE LA ACTIVACION DE LA RUTA CRK-C3G-RAP1 Y SU DESREGULACION EN ENFERMEDADES

PID2019-105763GB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

C3G self-regulatory mechanism revealed: implications for hematopoietic malignancies

  • Carabias, Arturo
  • Guerrero Arroyo, María del Carmen
  • Pereda, José M. de
© 2020 The Author(s)., Abnormally increased signaling by the GTPase RAP1 favors progression of diverse tumors. We have characterized the auto-regulation and activation of C3G (RAPGEF1), an activator of RAP1. This led us to discover mutations in non-Hodgkin’s lymphomas that activate C3G-RAP1 constitutively, suggesting that deregulation of C3G may favor the dissemination of tumor cells, The work described in this Auto Commentary was supported by the Spanish Ministry of Science and Innovation (MCINN), Agencia Estatal de Investigación, and the European Regional Development Fund (ERDF) [grants BFU2015-69499-P, PID2019-105763GB-I00, SAF2016-76588-C2 -2-R, PID2019-104143RB-C21]; and from the Consejería de Educación, Junta de Castilla y León [grant SA017U16]. A.C. was funded by MICINN [FPU14/06259]. The authors’ institution is supported by the Programa de Apoyo a Planes Estratégicos de Investigación de Estructuras de Investigación de Excelencia co-funded by Junta de Castilla y León and ERDF [CLC-2017-01].
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

EGFR-dependent tyrosine phosphorylation of integrin β4 is not required for downstream signaling events in cancer cell lines

  • Molder, Lisa te
  • Kreft, Maaike
  • Heemskerk, Niels
  • Schuring, Joyce
  • Pereda, José M. de
  • Wilhelmsen, Kevin
  • Sonnenberg, Arnoud
© The Author(s) 2021., In epithelial cancers, the epidermal growth factor receptor (EGFR) and integrin α6β4 are frequently overexpressed and found to synergistically activate intracellular signaling pathways that promote cell proliferation and migration. In cancer cells, the β4 subunit is phosphorylated at tyrosine residues not normally recognized as kinase substrates; however, the function of these phosphotyrosine residues in cancer cells is a subject of much debate. In EGFR-overexpressing carcinoma cells, we found that the Src family kinase (SFK) inhibitor PP2 reduces β4 tyrosine phosphorylation following the activation of EGFR. However, siRNA mediated knockdown of the SFKs Src, Fyn, Yes and Lyn, individually or in combination, did not affect the EGF-induced phosphorylation of β4. Using phospho-peptide affinity chromatography and mass spectrometry, we found that PLCγ1 binds β4 at the phosphorylated residues Y1422/Y1440, but were unable to verify this interaction in A431 carcinoma cells that overexpress the EGFR. Furthermore, using A431 cells devoid of β4 or reconstituted with phenylalanine specific mutants of β4, the activation of several downstream signaling pathways, including PLCγ/PKC, MAPK and PI3K/Akt, were not substantially affected. We conclude that tyrosine-phosphorylated β4 does not enhance EGFR-mediated signaling in EGFR-overexpressing cells, despite the fact that this integrin subunit is highly tyrosine phosphorylated in these cells., This work was supported by grants from the Netherlands Organization for Scientifc Research (NWO; Project Number 824.14.010) and the Dutch Cancer Society (Project Number 2013-5971). JdP acknowledges the Spanish Ministry of Science and Innovation (MCINN), Agencia Estatal de Investigación, and the European Regional Development Fund (ERDF) (Grant PID2019-105763 GB-I00).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Regulation of hemidesmosome dynamics and cell signaling by integrin α6β4

  • Molder, Lisa te
  • Pereda, José M. de
  • Sonnenberg, Arnoud
Hemidesmosomes (HDs) are specialized multiprotein complexes that connect the keratin cytoskeleton of epithelial cells to the extracellular matrix (ECM). In the skin, these complexes provide stable adhesion of basal keratinocytes to the underlying basement membrane. Integrin α6β4 is a receptor for laminins and plays a vital role in mediating cell adhesion by initiating the assembly of HDs. In addition, α6β4 has been implicated in signal transduction events that regulate diverse cellular processes, including proliferation and survival. In this Review, we detail the role of α6β4 in HD assembly and beyond, and we discuss the molecular mechanisms that regulate its function., J.M.d.P. is supported by grants from the Ministerio de Ciencia e Innovación (PID2019-105763GB-I00) and by the Junta de Castilla y León (SA078P20), which are partially supported by the European Regional Development Fund. The work of A.S. is supported by grants from the KWF Kankerbestrijding and the Nederlandse Organisatie voor Wetenschappelijk Onderzoek.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Crk proteins activate the Rap1 guanine nucleotide exchange factor C3G by segregated adaptor-dependent and -independent mechanisms

  • Rodríguez-Blázquez, Antonio
  • Carabias, Arturo
  • Morán-Vaquero, Alba
  • Cima, Sergio de
  • Luque-Ortega, Juan Román
  • Alfonso, Carlos
  • Schuck, Peter
  • Manso, José A.
  • Macedo-Ribeiro, Sandra
  • Guerrero Arroyo, María del Carmen
  • Pereda, José M. de
[Background]: C3G is a guanine nucleotide exchange factor (GEF) that activates Rap1 to promote cell adhesion. Resting C3G is autoinhibited and the GEF activity is released by stimuli that signal through tyrosine kinases. C3G is activated by tyrosine phosphorylation and interaction with Crk adaptor proteins, whose expression is elevated in multiple human cancers. However, the molecular details of C3G activation and the interplay between phosphorylation and Crk interaction are poorly understood. [Methods]: We combined biochemical, biophysical, and cell biology approaches to elucidate the mechanisms of C3G activation. Binding of Crk adaptor proteins to four proline-rich motifs (P1 to P4) in C3G was characterized in vitro using isothermal titration calorimetry and sedimentation velocity, and in Jurkat and HEK293T cells by affinity pull-down assays. The nucleotide exchange activity of C3G over Rap1 was measured using nucleotide-dissociation kinetic assays. Jurkat cells were also used to analyze C3G translocation to the plasma membrane and the C3G-dependent activation of Rap1 upon ligation of T cell receptors. [Results]: CrkL interacts through its SH3N domain with sites P1 and P2 of inactive C3G in vitro and in Jurkat and HEK293T cells, and these sites are necessary to recruit C3G to the plasma membrane. However, direct stimulation of the GEF activity requires binding of Crk proteins to the P3 and P4 sites. P3 is occluded in resting C3G and is essential for activation, while P4 contributes secondarily towards complete stimulation. Tyrosine phosphorylation of C3G alone causes marginal activation. Instead, phosphorylation primes C3G lowering the concentration of Crk proteins required for activation and increasing the maximum activity. Unexpectedly, optimal activation also requires the interaction of CrkL-SH2 domain with phosphorylated C3G. [Conclusion]: Our study revealed that phosphorylation of C3G by Src and Crk-binding form a two-factor mechanism that ensures tight control of C3G activation. Additionally, the simultaneous SH2 and SH3N interaction of CrkL with C3G, required for the activation, reveals a novel adaptor-independent function of Crk proteins relevant to understanding their role in physiological signaling and their deregulation in diseases., This work was supported by the Spanish Ministry of Science and Innovation, Agencia Estatal de Investigación, MCIN/AEI/https://doi.org/10.13039/501100011033 and by European Regional Development Fund “ERDF a way of making Europe” (grants PID2019-105763GB-I00 to JMdP, PID2019-104143RB-C21 to CG, PID2019-104544GB-I00 to CA); and from the Consejería de Educación, Junta de Castilla y León (grant SA078P20). This work was also supported by the Intramural Research Programs of the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, USA. ARB was funded by Banco Santander and University of Salamanca. AC was funded by MICINN (FPU14/06259). The authors’ institution is supported by the Programa de Apoyo a Planes Estratégicos de Investigación de Estructuras de Investigación de Excelencia co-funded by Junta de Castilla y León and ERDF (CLC-2017-01).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

LYP regulates SLP76 and other adaptor proteins in T cells

  • Ruiz-Martín, Virginia
  • Marcos de Mena, Tamara
  • Pereda, José M. de
  • Sánchez Crespo, Mariano
  • Fuente, Miguel A. de la
  • Bayón, Yolanda
  • Alonso, Andrés
[Background]: The LYP tyrosine phosphatase presents a SNP (1858C > T) that increases the risk of developing autoimmune diseases such as type I diabetes and arthritis. It remains unclear how this SNP affects LYP function and promotes the development of these diseases. The scarce information about LYP substrates is in part responsible for the poor understanding of LYP function., [Results]: In this study, we identify in T lymphocytes several adaptor proteins as potential substrates targeted by LYP, including FYB, SLP-76, HS-1, Vav, SKAP1 and SKAP2. We also show that LYP co-localizes with SLP76 in microclusters, upon TCR engagement., [Conclusions]: These data indicate that LYP may modulate T cell activation by dephosphorylating several adaptor proteins, such as FYB, SLP-76, HS-1, Vav, SKAP1 and SKAP2 upon TCR engagement., This work has been funded by Consejería de Sanidad de la Junta de Castilla y León, and by Programa Estratégico Instituto de Biología y Genética Molecular (IBGM), Junta de Castilla y León CCVC8485 and CLU-2019-02 (AA). JMdP’s research is supported by Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033) grant PID2019-105763GB-I00, and by Junta de Castilla y León grant CLC-2017-01, both co-funded by European Regional Development Fund “ERDF a way of making Europe., Peer reviewed